Navigation Links
Hepatitis B accounts for 40 percent of 'missing' Asian women

In a groundbreaking, sure-to-be-controversial new study, Emily Oster (a graduate student in economics at Harvard University) argues that excess female mortality, such as infanticide, may not be the only cause of uncommonly high male to female ratios in many Asian countries. It has long been observed that the relative number of males is higher in certain Asian countries than in the West, where it is close to unity. A number of authors have suggested that this imbalance reflects neglect of female children and poor conditions for women and, as a result, have argued that as many as 100 million women are "missing."

However, in the forthcoming issue of the Journal of Political Economy, Oster proposes an explanation for some of the observed over-representation of males: the hepatitis B virus. She presents new evidence, consistent with existing scientific literature, that carriers of the hepatitis B virus are 1.5 times more likely to have a male child. This evidence includes both cross-country analyses and natural experimentation based on recent vaccination campaigns. In addition, hepatitis B is common in many Asian countries, particularly China, where some 10 to 15 percent of the population is infected.

Using data on viral prevalence by country as well as estimates of the effect of hepatitis on birth sex, Oster concludes that hepatitis B can account for about 45 percent of the "missing women" ?or, more specifically, for as many as 50 percent of the "missing women" in Egypt and West Asia; under 20 percent in Bangladesh, India, Pakistan and Nepal; and around 75 percent of the "missing women" in China.


'"/>

Source:University of Chicago Press Journals


Page: 1

Related biology news :

1. Scientists Replicate Hepatitis C Virus in Laboratory
2. Norovirus, AIDS vaccine and Hepatitis Virus
3. UCLA study assesses cost-effectiveness of Hepatitis B drugs
4. Natural Killers Could Lead to New Hepatitis Treatments
5. FDA Approves New Treatment for Chronic Hepatitis B
6. Identification of specific genes predicts which patients will respond to Hepatitis C treatment
7. Hepatitis C responds best to combo of ribavirin and interferon, study concludes
8. Use of high hydrostatic pressure to inactivate Hepatitis A virus in oysters studied
9. Hepatitis C complicated by morphine withdrawal
10. Hepatitis C therapy: Inhibiting newly discovered microDNA molecule
11. Hepatitis E takes a piggyback
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/21/2016)... , June 21, 2016 NuData ... the new role of principal product architect and ... the director of customer development. Both will report ... technical officer. The moves reflect NuData,s strategic growth ... response to high customer demand and customer focus ...
(Date:6/9/2016)... an innovation leader in attendance control systems is proud to announce the introduction of ... make sure the right employees are actually signing in, and to even control the ... ... ... ...
(Date:6/2/2016)... 2, 2016 The Department of Transport ... the 44 million US Dollar project, for the , ... including Personalization, Enrolment, and IT Infrastructure , to ... production and implementation of Identity Management Solutions. Numerous renowned international ... Decatur was selected for the most compliant ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... ... , ... DrugDev believes the only way to achieve real change ... three tenets were on display at the 2nd Annual DrugDev User Summit (hosted by ... and site organizations to discuss innovation and the future of clinical research. , ...
(Date:12/2/2016)... December 2, 2016 The immunohistochemistry (IHC) ... at a CAGR of 7.3% during the forecast period of 2016 ... diagnostic laboratories segment accounted for the largest share of immunohistochemistry (IHC) ... , ... global immunohistochemistry (IHC) market spread across 225 pages, profiling 10 companies ...
(Date:11/30/2016)... TORONTO , Nov. 30, 2016 /PRNewswire/ - Portage ... Canadian Securities Exchange: PBT.U), is excited to announce ... company focused on developing preclinical ophthalmology assets through ... a potent anti-inflammatory created by Portage Pharmaceuticals Limited ... patients with ocular surface and anterior segment diseases. ...
(Date:11/30/2016)... BEIJING , Nov. 30, 2016 Novogene ... services and solutions with cutting edge next-generation sequencing (NGS) ... a USD $75 Million [515 Million RMB] B round ... Capital Management ( Shenzhen ) Co., Ltd. ... Innovation") and Shanghai Sigma Square Investment Center LP ("Sigma ...
Breaking Biology Technology: